Paradigm Biopharmaceuticals Limited Price Chart
Paradigm Biopharmaceuticals Limited PAR.XA Financial and Trading Overview
| Paradigm Biopharmaceuticals Limited stock price | 0.28 AUD |
| Previous Close | 0.92 AUD |
| Open | 0.94 AUD |
| Bid | 0.91 AUD x N/A |
| Ask | 0.92 AUD x N/A |
| Day's Range | 0.91 - 0.97 AUD |
| 52 Week Range | 0.81 - 2.16 AUD |
| Volume | 31.41K AUD |
| Avg. Volume | 106.89K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.140996 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.198 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PAR.XA Valuation Measures
| Enterprise Value | 167.65M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.505747 |
| Enterprise Value/Revenue | 4328.362 |
| Enterprise Value/EBITDA | -3.146 |
Trading Information
Paradigm Biopharmaceuticals Limited Stock Price History
| Beta (5Y Monthly) | 1.140996 |
| 52-Week Change | -6.34% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.16 AUD |
| 52 Week Low | 0.81 AUD |
| 50-Day Moving Average | 1.02 AUD |
| 200-Day Moving Average | 1.3 AUD |
PAR.XA Share Statistics
| Avg. Volume (3 month) | 106.89K AUD |
| Avg. Daily Volume (10-Days) | 88.27K AUD |
| Shares Outstanding | N/A |
| Float | 240.52M |
| Short Ratio | N/A |
| % Held by Insiders | 16.46% |
| % Held by Institutions | 19.20% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -137597.26% |
| Gross Margin | -107.73% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.70% |
| Return on Equity (ttm) | -69.72% |
Income Statement
| Revenue (ttm) | 38.73K AUD |
| Revenue Per Share (ttm) | 0 AUD |
| Quarterly Revenue Growth (yoy) | -89.60% |
| Gross Profit (ttm) | -64527 AUD |
| EBITDA | -53284852 AUD |
| Net Income Avi to Common (ttm) | -44131976 AUD |
| Diluted EPS (ttm) | -0.198 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 83.93M AUD |
| Total Cash Per Share (mrq) | 0.3 AUD |
| Total Debt (mrq) | 389.78K AUD |
| Total Debt/Equity (mrq) | 0.53 AUD |
| Current Ratio (mrq) | 5.892 |
| Book Value Per Share (mrq) | 0.261 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -33231114 AUD |
| Levered Free Cash Flow (ttm) | -22377408 AUD |
Profile of Paradigm Biopharmaceuticals Limited
| Country | Australia |
| State | VIC |
| City | Melbourne |
| Address | 500 Collins Street |
| ZIP | 3000 |
| Phone | 61 3 9629 5566 |
| Website | https://www.paradigmbiopharma.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.
Q&A For Paradigm Biopharmaceuticals Limited Stock
What is a current PAR.XA stock price?
Paradigm Biopharmaceuticals Limited PAR.XA stock price today per share is 0.28 AUD.
How to purchase Paradigm Biopharmaceuticals Limited stock?
You can buy PAR.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Paradigm Biopharmaceuticals Limited?
The stock symbol or ticker of Paradigm Biopharmaceuticals Limited is PAR.XA.
How many shares does Paradigm Biopharmaceuticals Limited have in circulation?
The max supply of Paradigm Biopharmaceuticals Limited shares is 0.
What is Paradigm Biopharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
Paradigm Biopharmaceuticals Limited PE Ratio is now.
What was Paradigm Biopharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
Paradigm Biopharmaceuticals Limited EPS is -0.198 AUD over the trailing 12 months.